HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

indium- 111- 1,4,7,10- tetraazacyclododecane- 1,4,7,10- tetraacetic acid

Also Known As:

111In-DOTA

Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - indium-111-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid: 3
Inorganic Chemicals: 9
- Coordination Complexes: 576
  - indium-111-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid: 3
Organic Chemicals: 133
- Coordination Complexes: 576
  - indium-111-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid: 3

Experts

1.	Buijs, Jos: 1 article (11/2017)
2.	Garousi, Javad: 1 article (11/2017)
3.	Hober, Sophia: 1 article (11/2017)
4.	Lindbo, Sarah: 1 article (11/2017)
5.	Mitran, Bogdan: 1 article (11/2017)
6.	Orlova, Anna: 1 article (11/2017)
7.	Tolmachev, Vladimir: 1 article (11/2017)
8.	Vorobyeva, Anzhelika: 1 article (11/2017)
9.	Anderson, Anne-Line: 1 article (07/2005)
10.	Crow, Desiree: 1 article (07/2005)

Related Diseases

1.

Neoplasms (Cancer)

11/07/2017 - "The 111In-DOTA label provided 2-6 fold higher tumor-to-organ ratios than 99mTc-GSSC and is therefore the preferable label for ADAPTs."
07/01/2005 - "Furthermore, in non-tumor-bearing mice, 111In-DOTA hu4D5v8 minibody exhibited similar elevated uptake in the kidneys (28.4 +/- 6.5% ID/g). "
07/01/2005 - "The tumor uptake of 111In-DOTA 10H8 minibody was 5.7 +/- 0.1% ID/g, similar to the radioiodinated 10H8 minibody. "
02/15/1992 - "Eight patients with various malignant tumors received low doses (220 micrograms to 1 mg) of monoclonal antibodies, labeled with 111In-DOTA, i.v. for imaging studies. "

Related Drugs and Biologics

1.	Monoclonal Antibodies